1. Home
  2. XGN vs SRG Comparison

XGN vs SRG Comparison

Compare XGN & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • SRG
  • Stock Information
  • Founded
  • XGN 2002
  • SRG 2014
  • Country
  • XGN United States
  • SRG United States
  • Employees
  • XGN N/A
  • SRG N/A
  • Industry
  • XGN Medical Specialities
  • SRG Real Estate Investment Trusts
  • Sector
  • XGN Health Care
  • SRG Real Estate
  • Exchange
  • XGN Nasdaq
  • SRG Nasdaq
  • Market Cap
  • XGN 138.3M
  • SRG 163.3M
  • IPO Year
  • XGN 2019
  • SRG 2015
  • Fundamental
  • Price
  • XGN $6.92
  • SRG $2.76
  • Analyst Decision
  • XGN Strong Buy
  • SRG
  • Analyst Count
  • XGN 2
  • SRG 0
  • Target Price
  • XGN $7.50
  • SRG N/A
  • AVG Volume (30 Days)
  • XGN 374.9K
  • SRG 122.6K
  • Earning Date
  • XGN 05-05-2025
  • SRG 05-15-2025
  • Dividend Yield
  • XGN N/A
  • SRG N/A
  • EPS Growth
  • XGN N/A
  • SRG N/A
  • EPS
  • XGN N/A
  • SRG N/A
  • Revenue
  • XGN $56,724,000.00
  • SRG N/A
  • Revenue This Year
  • XGN $19.39
  • SRG N/A
  • Revenue Next Year
  • XGN $13.27
  • SRG N/A
  • P/E Ratio
  • XGN N/A
  • SRG N/A
  • Revenue Growth
  • XGN 1.78
  • SRG N/A
  • 52 Week Low
  • XGN $1.71
  • SRG $2.43
  • 52 Week High
  • XGN $7.20
  • SRG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • XGN 62.02
  • SRG 37.10
  • Support Level
  • XGN $6.51
  • SRG $2.81
  • Resistance Level
  • XGN $7.20
  • SRG $2.91
  • Average True Range (ATR)
  • XGN 0.51
  • SRG 0.09
  • MACD
  • XGN 0.04
  • SRG -0.01
  • Stochastic Oscillator
  • XGN 81.15
  • SRG 17.14

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.

Share on Social Networks: